AM-1125

N/A

Report date: 2023/03/12 14:23:37
NME

Base Information

Drug NameAM-1125
Drug Alias NameAM-1125
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2b (5-HT2b) receptor antagonists
TargetsSerotonin 2b (5-HT2b) receptor
Therapy Area/IndicationsScleroderma, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnamar Ab
China Registration ClassN/A

Develop Information

Active CompaniesAnamar Ab
Inactive CompaniesN/A
Active IndicationsScleroderma, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A